WO2006036817A3 - Fungal variants and uses thereof - Google Patents

Fungal variants and uses thereof Download PDF

Info

Publication number
WO2006036817A3
WO2006036817A3 PCT/US2005/034219 US2005034219W WO2006036817A3 WO 2006036817 A3 WO2006036817 A3 WO 2006036817A3 US 2005034219 W US2005034219 W US 2005034219W WO 2006036817 A3 WO2006036817 A3 WO 2006036817A3
Authority
WO
WIPO (PCT)
Prior art keywords
fungal
variants
compositions
treating
methods
Prior art date
Application number
PCT/US2005/034219
Other languages
French (fr)
Other versions
WO2006036817A2 (en
Inventor
G Todd Milne
Original Assignee
Microbia Inc
G Todd Milne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbia Inc, G Todd Milne filed Critical Microbia Inc
Publication of WO2006036817A2 publication Critical patent/WO2006036817A2/en
Publication of WO2006036817A3 publication Critical patent/WO2006036817A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Abstract

Methods and compositions for treating and inhibiting fungal infections are described herein.
PCT/US2005/034219 2004-09-24 2005-09-23 Fungal variants and uses thereof WO2006036817A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61311204P 2004-09-24 2004-09-24
US60/613,112 2004-09-24

Publications (2)

Publication Number Publication Date
WO2006036817A2 WO2006036817A2 (en) 2006-04-06
WO2006036817A3 true WO2006036817A3 (en) 2006-07-27

Family

ID=36119465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/034219 WO2006036817A2 (en) 2004-09-24 2005-09-23 Fungal variants and uses thereof

Country Status (1)

Country Link
WO (1) WO2006036817A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
WO2008109833A2 (en) * 2007-03-07 2008-09-12 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides identified by iviat screening and methods of use
FR2921260B1 (en) 2007-09-25 2012-08-24 Lesaffre & Cie USE OF A NEW NATURAL AGENT IN COSMETIC COMPOSITIONS
GEP201706766B (en) 2011-07-22 2017-10-25 Los Angeles Biomedical Res Center Methods and compositions for vaccinating against staphylococcus aureus
WO2014144211A2 (en) * 2013-03-15 2014-09-18 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
GB201306588D0 (en) * 2013-04-11 2013-05-29 King S College London Peptides and Binding Partners Therefor
BR112015032695A2 (en) 2013-07-04 2017-10-24 Glykos Finland Oy o-mannosyltransferase-deficient filamentous fungal cells and methods of using them
US10513724B2 (en) 2014-07-21 2019-12-24 Glykos Finland Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
EP3426287A4 (en) 2016-03-09 2020-03-11 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Methods and kits for use in preventing and treating vulvovaginal candidiasis
CN111870683B (en) * 2020-09-17 2021-08-27 烟台市华昕生物医药科技有限公司 Application of antibacterial peptide in preparation of medicines or cosmetics

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030039667A1 (en) * 2001-08-27 2003-02-27 Vic Jira Anti-fungal composition
US20030176367A1 (en) * 2000-08-25 2003-09-18 Microbia, Inc. A Delaware Corportion Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections
US6638756B2 (en) * 2000-12-05 2003-10-28 California Institute Of Technology Chimeric cell-targeting pathogenic organism and method of therapeutic use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030176367A1 (en) * 2000-08-25 2003-09-18 Microbia, Inc. A Delaware Corportion Use of sublethal concentrations of anti-invasin compounds to therapeutically or prophylactically treat fungal infections
US6638756B2 (en) * 2000-12-05 2003-10-28 California Institute Of Technology Chimeric cell-targeting pathogenic organism and method of therapeutic use
US20030039667A1 (en) * 2001-08-27 2003-02-27 Vic Jira Anti-fungal composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GALE C. A. ET AL.: "Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INTI", SCIENCE, vol. 279, February 1998 (1998-02-01), pages 1355 - 1358, XP002954887 *

Also Published As

Publication number Publication date
WO2006036817A2 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
WO2006036817A3 (en) Fungal variants and uses thereof
WO2007146965A3 (en) Compounds for the treatment of periodontal disease
WO2006023649A3 (en) Treatment of severe multiple sclerosis
EP1868628A4 (en) Compounds, compositions and methods for the treatment of poxvirus infections
WO2006050477A3 (en) Anti-microbial compositions and methods of making and using the same
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
WO2008115281A3 (en) Compounds for treating viral infections
ZA200700351B (en) Compounds, compositions and methods
ZA200701629B (en) Gyrase inhibitors and uses thereof
WO2006034035A3 (en) Treatment of ischemia
WO2006003492A3 (en) Compositions and methods for treating pathological infections
WO2006099131A3 (en) Elasmobranch-repelling magnets and methods of use
WO2008027600A3 (en) Imatinib compositions
WO2007070613A3 (en) Rifamycin analogs and uses thereof
WO2008060795A3 (en) Antimicrobial articles and method of manufacture
WO2006044378A3 (en) Rapid computational identification of targets
WO2008133734A3 (en) Method and compositions for treating hiv infections
WO2007059226A3 (en) Photoactivatable antimicrobial agents
WO2007140205A3 (en) Methods of treating fibrosis
WO2007067784A3 (en) Liposomal compositions
WO2006078998A3 (en) Methods and compositions for decreasing saliva production
WO2008137128A3 (en) Methods of treating fungal infections
WO2007089612A3 (en) Methods and compositions for treating and preventing bacterial infections
WO2007132355A3 (en) Compositions and methods for inhibiting viral adhesion
WO2006127978A3 (en) Compositions and methods for the treatment of cancer

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase